Correlation Between Biodexa Pharmaceticals and Indaptus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Biodexa Pharmaceticals and Indaptus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biodexa Pharmaceticals and Indaptus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biodexa Pharmaceticals and Indaptus Therapeutics, you can compare the effects of market volatilities on Biodexa Pharmaceticals and Indaptus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biodexa Pharmaceticals with a short position of Indaptus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biodexa Pharmaceticals and Indaptus Therapeutics.
Diversification Opportunities for Biodexa Pharmaceticals and Indaptus Therapeutics
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Biodexa and Indaptus is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Biodexa Pharmaceticals and Indaptus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indaptus Therapeutics and Biodexa Pharmaceticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biodexa Pharmaceticals are associated (or correlated) with Indaptus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indaptus Therapeutics has no effect on the direction of Biodexa Pharmaceticals i.e., Biodexa Pharmaceticals and Indaptus Therapeutics go up and down completely randomly.
Pair Corralation between Biodexa Pharmaceticals and Indaptus Therapeutics
Given the investment horizon of 90 days Biodexa Pharmaceticals is expected to generate 0.93 times more return on investment than Indaptus Therapeutics. However, Biodexa Pharmaceticals is 1.07 times less risky than Indaptus Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Indaptus Therapeutics is currently generating about 0.1 per unit of risk. If you would invest 409.00 in Biodexa Pharmaceticals on November 3, 2024 and sell it today you would earn a total of 32.00 from holding Biodexa Pharmaceticals or generate 7.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biodexa Pharmaceticals vs. Indaptus Therapeutics
Performance |
| Timeline |
| Biodexa Pharmaceticals |
| Indaptus Therapeutics |
Biodexa Pharmaceticals and Indaptus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biodexa Pharmaceticals and Indaptus Therapeutics
The main advantage of trading using opposite Biodexa Pharmaceticals and Indaptus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biodexa Pharmaceticals position performs unexpectedly, Indaptus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will offset losses from the drop in Indaptus Therapeutics' long position.| Biodexa Pharmaceticals vs. Molecular Partners AG | Biodexa Pharmaceticals vs. Southwest Airlines | Biodexa Pharmaceticals vs. American Airlines Group | Biodexa Pharmaceticals vs. Allegiant Travel |
| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |